Xenon Pharmaceuticals
XENE
XENE
58 hedge funds and large institutions have $110M invested in Xenon Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 23 increasing their positions, 6 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
-1
Holders Change %
-1.69%
% of All Funds
1.29%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
12
Increased
23
Reduced
6
Closed
12
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
–
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$3.93M |
| 2 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$2.26M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$2.05M |
| 4 |
BlackRock
New York
|
+$1.79M |
| 5 |
JPMorgan Chase & Co
New York
|
+$1.14M |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$11.8M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$7.01M |
| 3 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
-$5.09M |
| 4 |
JG
Jefferies Group
New York
|
-$4.3M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
-$3.96M |
